Each 75-, 110- and 150 mg cap contains β-alanine, N-[[2-[[[4(hexyloxy)carbonyl]amino]iminomethyl]phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-,ethyl ester, methane-sulfonate, being the methane sulfonic acid salt 86.48 mg, 126.83 mg or 172.95 mg corresponding to dabigatran etexilate base form 75 mg, 110 mg or 150 mg, respectively.
It also contains the following excipients: Tartaric acid, acacia, hypromellose, dimethicone 350, talc, hydroxypropyl cellulose. HPMC Capsule Shell: Carragenan, potassium chloride, titanium dioxide, sunset yellow (E110), indigo carmine (E132), hypromellose. Printing Ink: Shellac, N-butyl alcohol, isopropyl alcohol, industrial methylated spirit, black iron oxide (E172), purified water, propylene glycol.